Development of aldose reductase inhibitors for the treatment of inflammatory disorders

Author： Chatzopoulou Maria   Pegklidou Kyriaki   Papastavrou Nikolaos   Demopoulos Vassilis J  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.11, 2013-11, pp. : 1365-1380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases

By Pandey Saumya   Srivastava Satish K   Ramana Kota V  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 329-339

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

By Miyamoto Shuichi  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 621-631

Informa Healthcare

Access to resources Recommend Favorite

Aldose Reductase Inhibitors from the Nature

By  

Current Medicinal Chemistry, Vol. 10, Iss. 15, 2003-08 ,pp. : 1353-1374

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Aldose Reductase for the Treatment of Cancer

By  

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. : 560-571

Bentham Science Publishers

Access to resources Recommend Favorite

Phenylsulfonylnitromethanes as potent irreversible inhibitors of aldose reductase

By Saab N.H.   Donkor I.O.   Rodriguez L.   Kador P.F.   Miller D.D.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 9, 1999-09 ,pp. : 745-751

Elsevier

Access to resources Recommend Favorite